Catalogo dei prodotti della ricerca

SCUDERI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.889
EU - Europa 1.017
AS - Asia 425
AF - Africa 121
SA - Sud America 41
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.858
IT - Italia 645
IN - India 219
CN - Cina 151
SE - Svezia 78
UA - Ucraina 73
TG - Togo 71
FI - Finlandia 68
NG - Nigeria 43
DE - Germania 38
AR - Argentina 35
SG - Singapore 33
CA - Canada 30
GB - Regno Unito 22
BG - Bulgaria 21
IE - Irlanda 17
FR - Francia 16
BE - Belgio 7
BR - Brasile 6
HK - Hong Kong 6
NL - Olanda 6
CH - Svizzera 4
ES - Italia 4
IR - Iran 4
JP - Giappone 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
TR - Turchia 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZA - Sudafrica 3
AU - Australia 2
DK - Danimarca 2
IL - Israele 2
KR - Corea 2
NZ - Nuova Zelanda 2
PL - Polonia 2
GR - Grecia 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
Totale 4.500
Salva come PNG Salva come JPEG
Città #
Fairfield 419
Rome 361
Chandler 337
Ashburn 197
Houston 171
Wilmington 165
Seattle 159
Woodbridge 157
Cambridge 123
Princeton 113
Beijing 94
Ann Arbor 93
Plano 84
Lomé 71
Millbury 61
San Paolo di Civitate 53
Boston 50
Dearborn 48
Lawrence 37
Federal 35
Andover 32
San Diego 30
Grafing 24
Sofia 21
Norwalk 20
San Mateo 20
Toronto 20
Jacksonville 18
Singapore 18
Dublin 17
Boardman 16
Milan 15
Helsinki 14
Surat 13
New York 11
Los Angeles 10
Des Moines 9
Falls Church 8
Guidonia Montecelio 8
Sacramento 8
Bologna 7
Brussels 7
Nanjing 7
Palermo 7
Buffalo 6
Bühl 6
Hefei 5
Kunming 5
San Jose 5
San Nicola la Strada 5
Florence 4
Genoa 4
Indiana 4
Kai Yi Wan 4
La Spezia 4
Lucknow 4
Newton Upper Falls 4
Ottawa 4
Paradise 4
Paris 4
Pescara 4
Phoenix 4
Saint-cyprien 4
Aprilia 3
Bari 3
Bussi sul Tirino 3
Catania 3
Collecchio 3
Laurel 3
London 3
Moscow 3
Nanchang 3
Naples 3
Pristina 3
Redwood City 3
Rochester 3
Shanghai 3
Shenyang 3
Tunis 3
Washington 3
Adachi 2
Amsterdam 2
Baotou 2
Barcelos 2
Belluno 2
Bern 2
Caserta 2
Casnate Con Bernate 2
Castellammare di Stabia 2
Castrovillari 2
Chengdu 2
Chongqing 2
Cinisello Balsamo 2
Copenhagen 2
Coruripe 2
Dovera 2
Fuzhou 2
Guangzhou 2
Hebei 2
Hobart 2
Totale 3.363
Salva come PNG Salva come JPEG
Nome #
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 105
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice 99
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 95
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement 95
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease 83
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder 82
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 81
Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders 80
Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders 78
Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. 78
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide 78
Opposing control of cannabinoid receptor stimulation on amyloid-{beta} induced reactive gliosis: in vitro and in vivo evidence. 77
Astrocyte: an innovative approach for Alzheimer's disease therapy 76
Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence 75
Neuroglia in the autistic brain: evidence from a preclinical model 73
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes 72
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α 70
S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors 68
null 67
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes 67
Sorafenib chemosensitization by caryophyllane sesquiterpenes in liver, biliary, and pancreatic cancer cells: the role of STAT3/ABC transporter axis 66
S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. 65
S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells 65
Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders? 65
How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy? 61
Role of astrocytes in major neurological disorders: The evidence and implications 60
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ? 60
How could retinoids fit into Alzheimer's therapy? 60
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. 60
The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice 60
CB1 receptor selective activation inhibits β-amyloid-induced Inos protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons 59
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis 59
Editorial: Neuroglia Molecular Mechanisms in Psychiatric Disorders 56
Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection 55
Are Retinoids a Promise for Alzheimer's Disease Management? 54
Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement 54
Cannabinoid CB(1) receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. 53
An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid beta-peptide (Abeta) 50
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer's Disease 49
Sirtuin modulators control reactive gliosis in an in vitro model of alzheimer's disease 47
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview 46
Cannabidiol in vivo suppresses Aβ-induced reactive gliosis. 45
Neuroinflammation in Alzheimer's disease: friend or foe? 42
S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein up-regulation and relative Wnt pathway disruption in cultured human neurons. 40
The role of neuroglia in autism spectrum disorders 40
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 40
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 38
Preparation of rat hippocampal organotypic cultures and application to study amyloid beta-peptide toxicity 38
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 38
Targeting neuroinflammation in Alzheimer’s disease 36
Ultramicronized palmitoylethanolamide improves learning and memory in a triple transgenic mouse model of Alzheimer's disease through a combination of anti-inflammatory and neuroprotective effects 36
Possibile ruolo delle ALIAmidi nelle patologie degenerative del sistema nervoso. 35
Genomic and functional profiling of human Down syndrome neural progenitor implicates S100B and Aquaporin 4 in cell injury 35
null 35
The protective effects of ultramicronized palmitoylethanolamide on the glutamatergic system in a triple transgene mouse model of Alzheimer disease. 34
Astrocyte-neuron interplay in Alzheimer's disease: evidence from an innovative and promising pharmacological manipulation in a triple transgenic model of the disease 33
Antinflammatory/neuroprotective properties of palmitoylethanolamide in a model of Alzheimer’s disease 32
Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease 32
Palmitoylethanolamide counteracts reactive gliosis in an in vivo model of Alzheimer’s disease 31
Anti-inflammatory/neuroprotective properties of palmitoylethanolamide in a model of beta amyloid neurotoxicity. 31
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 31
Successful and unsuccessful brain aging in pets: Pathophysiological mechanisms behind clinical signs and potential benefits from palmitoylethanolamide nutritional intervention 31
Neuroglia in Psychiatric Disorders 31
Cannabidiol controls intestinal inflammation through the modulation of enteric glial cell activation. 30
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 30
Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease 29
PPARγ mediates cannabidiol antiinflammatory and neuroprotective effects in an in vitro model of Alzheimer’s disease. 29
Glia and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression 29
Targeting the oxytocinergic system: A possible pharmacological strategy for the treatment of inflammation occurring in different chronic diseases 29
Cannabinoids and PPARs: new tools for Alzheimer’s disease treatment. 28
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 28
Quale futuro per la terapia delle malattie neurodegenerative:nuove evidenze dalla ricerca preclinica. 28
Palmitoylethanolamide is able to attenuate astrocyte activation and neuroinflammation in models of Alzheimer’s desease 28
Proprietà antinfiammatorie della PEA in cellule C6 stimolate con il peptide beta amiloide 27
The Importance of the Enteric Glia and its Related Product S100b Protein in Gut Inflammation 27
Investigating the role of oligodendrocytes in a pharmacological model of autism spectrum disorders 27
Prenatal ethanol exposure affects endocannabinoids levels in prefrontal cortex of adult rat offspring 26
Resilient and vulnerable rats to acute foot shock stress show different glial cell responses: possible rescue of pathological alterations by a single ketamine administration 25
Dual control by cannabinoid CB1 and CB2 receptors of S100B protein expression and glial cell proliferation following administration of beta amyloid in vitro and in vivo. 25
Sirtuins blunt reactive gliosis in an in vitro model of Alzheimer’s disease. 25
Astrocytes and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression. Evidence from a triple transgenic model of the disease 25
Effect of ultramicronized-palmytoilethanolamide on astrocyte dysfunction in a triple transgenic model of Alzheimer’s disease 25
Principles of Astrogliopathology 25
Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants 25
Palmitoylethanolamide blunts beta amyloid-induced reactive astrogliosis. 24
Neuroprotective effects of palmitoylethanolamide in Alzheimer’s disease 24
Palmitoylethanolamide exerts neuroprotective effects in an in vivo model of Alzheimer’s disease 24
De Filippis D., Esposito G, Savani C, Scuderi C, D’Amico A, Di Marzo V, Steardo L, Teresa Iuvone. 24
Effect of palmytoilethanolamide in 3xTg-AD astrocytes as in vitro model of Alzheimer’s disease 24
Astrocytes: The Housekeepers and Guardians of the CNS 24
Hippocampal metabolic and behavioural improvements after palmitoylethanolamide treatment at early stage of development in a triple transgene mouse model of Alzheimer disease. 23
Opposing control of cannabinoid receptor stimulation on amyloid-β induced reactive gliosis: in vitro and in vivo evidence. 23
Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame? 23
Looking for a treatment for the early stage of Alzheimer’s disease: preclinical evidence with co-ultramicronized palmitoylethanolamide and luteolin 22
Effects of palmitoylethanolamide on the onset and progression of the pathology on a triple transgene mouse model of Alzheimer disease. 22
Effect of palmitoylethanolamide in a triple transgenic model of Alzheimer’s disease 21
Glial dysfunction in the pathogenesis of neuropsychiatric disorders: beyond inflammation, toward the development of novel therapies 21
Quale futuro per la terapia dell'Alzheimer? Evidenze dalla ricerca preclinica. 21
Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders 20
Astrocytes in Psychiatric Disorders 20
Totale 4.517
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019326 0 0 0 0 0 0 0 0 0 0 171 155
2019/2020908 154 24 31 37 74 114 127 85 88 85 55 34
2020/2021370 30 34 9 25 12 4 8 31 59 64 41 53
2021/20221.073 23 51 86 11 116 95 18 118 100 86 161 208
2022/20231.135 227 226 58 76 157 110 15 54 134 21 38 19
2023/2024490 33 94 22 54 48 57 29 68 7 71 7 0
Totale 4.711